Global Artificial Pulmonary Valve System Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Artificial Pulmonary Valve System market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Artificial Pulmonary Valve System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Artificial Pulmonary Valve System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Artificial Pulmonary Valve System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Artificial Pulmonary Valve System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Artificial Pulmonary Valve System include Edwards Lifesciences, Epicor Medical, Terumo, Valtech Cardio, Boston Scientific, Venus Medtech Medical Device, Medtronic and Abbott, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Artificial Pulmonary Valve System, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Artificial Pulmonary Valve System, also provides the sales of main regions and countries. Of the upcoming market potential for Artificial Pulmonary Valve System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Pulmonary Valve System sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Artificial Pulmonary Valve System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Artificial Pulmonary Valve System sales, projected growth trends, production technology, application and end-user industry.

Artificial Pulmonary Valve System Segment by Company

Edwards Lifesciences
Epicor Medical
Terumo
Valtech Cardio
Boston Scientific
Venus Medtech Medical Device
Medtronic
Abbott
Artificial Pulmonary Valve System Segment by Type

PLA
PCL
Others
Artificial Pulmonary Valve System Segment by Application

Pulmonary Valve Regurgitation
Pulmonary Valve Stenosis
Pulmonary Hypertension
Others
Artificial Pulmonary Valve System Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pulmonary Valve System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pulmonary Valve System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pulmonary Valve System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artificial Pulmonary Valve System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Pulmonary Valve System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artificial Pulmonary Valve System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Artificial Pulmonary Valve System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Artificial Pulmonary Valve System Market Size, 2020 VS 2024 VS 2031
1.3 Global Artificial Pulmonary Valve System Market Size Estimates and Forecasts (2020-2031)
1.4 Global Artificial Pulmonary Valve System Sales Estimates and Forecasts (2020-2031)
1.5 Global Artificial Pulmonary Valve System Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Artificial Pulmonary Valve System Market Dynamics
2.1 Artificial Pulmonary Valve System Industry Trends
2.2 Artificial Pulmonary Valve System Industry Drivers
2.3 Artificial Pulmonary Valve System Industry Opportunities and Challenges
2.4 Artificial Pulmonary Valve System Industry Restraints
3 Artificial Pulmonary Valve System Market by Manufacturers
3.1 Global Artificial Pulmonary Valve System Revenue by Manufacturers (2020-2025)
3.2 Global Artificial Pulmonary Valve System Sales by Manufacturers (2020-2025)
3.3 Global Artificial Pulmonary Valve System Average Sales Price by Manufacturers (2020-2025)
3.4 Global Artificial Pulmonary Valve System Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Artificial Pulmonary Valve System Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Artificial Pulmonary Valve System Manufacturers, Product Type & Application
3.7 Global Artificial Pulmonary Valve System Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Artificial Pulmonary Valve System Market CR5 and HHI
3.8.2 Global Top 5 and 10 Artificial Pulmonary Valve System Players Market Share by Revenue in 2024
3.8.3 2024 Artificial Pulmonary Valve System Tier 1, Tier 2, and Tier 3
4 Artificial Pulmonary Valve System Market by Type
4.1 Artificial Pulmonary Valve System Type Introduction
4.1.1 PLA
4.1.2 PCL
4.1.3 Others
4.2 Global Artificial Pulmonary Valve System Sales by Type
4.2.1 Global Artificial Pulmonary Valve System Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Artificial Pulmonary Valve System Sales by Type (2020-2031)
4.2.3 Global Artificial Pulmonary Valve System Sales Market Share by Type (2020-2031)
4.3 Global Artificial Pulmonary Valve System Revenue by Type
4.3.1 Global Artificial Pulmonary Valve System Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Artificial Pulmonary Valve System Revenue by Type (2020-2031)
4.3.3 Global Artificial Pulmonary Valve System Revenue Market Share by Type (2020-2031)
5 Artificial Pulmonary Valve System Market by Application
5.1 Artificial Pulmonary Valve System Application Introduction
5.1.1 Pulmonary Valve Regurgitation
5.1.2 Pulmonary Valve Stenosis
5.1.3 Pulmonary Hypertension
5.1.4 Others
5.2 Global Artificial Pulmonary Valve System Sales by Application
5.2.1 Global Artificial Pulmonary Valve System Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Artificial Pulmonary Valve System Sales by Application (2020-2031)
5.2.3 Global Artificial Pulmonary Valve System Sales Market Share by Application (2020-2031)
5.3 Global Artificial Pulmonary Valve System Revenue by Application
5.3.1 Global Artificial Pulmonary Valve System Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Artificial Pulmonary Valve System Revenue by Application (2020-2031)
5.3.3 Global Artificial Pulmonary Valve System Revenue Market Share by Application (2020-2031)
6 Global Artificial Pulmonary Valve System Sales by Region
6.1 Global Artificial Pulmonary Valve System Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Artificial Pulmonary Valve System Sales by Region (2020-2031)
6.2.1 Global Artificial Pulmonary Valve System Sales by Region (2020-2025)
6.2.2 Global Artificial Pulmonary Valve System Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Artificial Pulmonary Valve System Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Artificial Pulmonary Valve System Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Artificial Pulmonary Valve System Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Artificial Pulmonary Valve System Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Artificial Pulmonary Valve System Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Artificial Pulmonary Valve System Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Artificial Pulmonary Valve System Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Artificial Pulmonary Valve System Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Artificial Pulmonary Valve System Revenue by Region
7.1 Global Artificial Pulmonary Valve System Revenue by Region
7.1.1 Global Artificial Pulmonary Valve System Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Artificial Pulmonary Valve System Revenue by Region (2020-2025)
7.1.3 Global Artificial Pulmonary Valve System Revenue by Region (2026-2031)
7.1.4 Global Artificial Pulmonary Valve System Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Artificial Pulmonary Valve System Revenue (2020-2031)
7.2.2 North America Artificial Pulmonary Valve System Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Artificial Pulmonary Valve System Revenue (2020-2031)
7.3.2 Europe Artificial Pulmonary Valve System Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Artificial Pulmonary Valve System Revenue (2020-2031)
7.4.2 Asia-Pacific Artificial Pulmonary Valve System Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Artificial Pulmonary Valve System Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Artificial Pulmonary Valve System Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Edwards Lifesciences
8.1.1 Edwards Lifesciences Comapny Information
8.1.2 Edwards Lifesciences Business Overview
8.1.3 Edwards Lifesciences Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Edwards Lifesciences Artificial Pulmonary Valve System Product Portfolio
8.1.5 Edwards Lifesciences Recent Developments
8.2 Epicor Medical
8.2.1 Epicor Medical Comapny Information
8.2.2 Epicor Medical Business Overview
8.2.3 Epicor Medical Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Epicor Medical Artificial Pulmonary Valve System Product Portfolio
8.2.5 Epicor Medical Recent Developments
8.3 Terumo
8.3.1 Terumo Comapny Information
8.3.2 Terumo Business Overview
8.3.3 Terumo Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Terumo Artificial Pulmonary Valve System Product Portfolio
8.3.5 Terumo Recent Developments
8.4 Valtech Cardio
8.4.1 Valtech Cardio Comapny Information
8.4.2 Valtech Cardio Business Overview
8.4.3 Valtech Cardio Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Valtech Cardio Artificial Pulmonary Valve System Product Portfolio
8.4.5 Valtech Cardio Recent Developments
8.5 Boston Scientific
8.5.1 Boston Scientific Comapny Information
8.5.2 Boston Scientific Business Overview
8.5.3 Boston Scientific Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Boston Scientific Artificial Pulmonary Valve System Product Portfolio
8.5.5 Boston Scientific Recent Developments
8.6 Venus Medtech Medical Device
8.6.1 Venus Medtech Medical Device Comapny Information
8.6.2 Venus Medtech Medical Device Business Overview
8.6.3 Venus Medtech Medical Device Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Venus Medtech Medical Device Artificial Pulmonary Valve System Product Portfolio
8.6.5 Venus Medtech Medical Device Recent Developments
8.7 Medtronic
8.7.1 Medtronic Comapny Information
8.7.2 Medtronic Business Overview
8.7.3 Medtronic Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Medtronic Artificial Pulmonary Valve System Product Portfolio
8.7.5 Medtronic Recent Developments
8.8 Abbott
8.8.1 Abbott Comapny Information
8.8.2 Abbott Business Overview
8.8.3 Abbott Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Abbott Artificial Pulmonary Valve System Product Portfolio
8.8.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Artificial Pulmonary Valve System Value Chain Analysis
9.1.1 Artificial Pulmonary Valve System Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Artificial Pulmonary Valve System Production Mode & Process
9.2 Artificial Pulmonary Valve System Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Artificial Pulmonary Valve System Distributors
9.2.3 Artificial Pulmonary Valve System Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings